Theracosbio Company Profile
✉ Email this page to a colleague
What is the competitive landscape for THERACOSBIO, and what generic alternatives to THERACOSBIO drugs are available?
THERACOSBIO has one approved drug.
There are six US patents protecting THERACOSBIO drugs.
There are sixty patent family members on THERACOSBIO drugs in thirty-two countries.
Summary for Theracosbio
| International Patents: | 60 |
| US Patents: | 6 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Theracosbio
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Theracosbio | BRENZAVVY | bexagliflozin | TABLET;ORAL | 214373-001 | Jan 20, 2023 | RX | Yes | Yes | 7,838,499 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| Theracosbio | BRENZAVVY | bexagliflozin | TABLET;ORAL | 214373-001 | Jan 20, 2023 | RX | Yes | Yes | 10,981,942 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| Theracosbio | BRENZAVVY | bexagliflozin | TABLET;ORAL | 214373-001 | Jan 20, 2023 | RX | Yes | Yes | 8,802,637 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
